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OBJECTIVE: The objective of this study was to evaluate the effects of Tualang honey on trabecular structure and
compare these effects with those of calcium supplementation in ovariectomized rats.
METHODS: Forty female, Sprague-Dawley rats were randomly divided into five groups (n =8): four controls and one
test arm. The control arm comprised a baseline control, sham-operated control, ovariectomized control, and
ovariectomized calcium-treated rats (receiving 1% calcium in drinking water ad libitum). The test arm was
composed of ovariectomized, Tualang honey-treated rats (received 0.2 g/kg body weight of Tualang honey). Both
the sham-operated control and ovariectomized control groups received vehicle treatment (deionized water), and
the baseline control group was sacrificed without treatment.
RESULTS: All rats were orally gavaged daily for six weeks after day one post-surgery. The bone structural analysis of
rats in the test arm group showed a significant increase in the bone volume per tissue volume (BV/TV), trabecular
thickness (Tb.Th) and trabecular number (Tb.N) and a significant decrease in inter-trabecular space (Tb.Sp)
compared with the ovariectomized control group. The trabecular thickness (Tb.Th) in the test arm group was
significantly higher compared with the ovariectomized-calcium treated group, and the inter-trabecular space
(Tb.Sp) in the test arm group was significantly narrower compared with the ovariectomized-calcium treated group.
CONCLUSION: In conclusion, ovariectomized rats that received Tualang honey showed more improvements in
trabecular bone structure than the rats that received calcium.
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In women, bone loss progresses much more rapidly after
menopause due to estrogen deficiency (1). Declining serum
estradiol levels can increase the lifespan of osteoclasts,
leading to bone resorption; however, the lifespan of
osteoblasts decreases, leading to less bone being formed.
Ovariectomized rats are widely used as an animal model for
the menopausal state because of the similarities in bone
changes (2). In postmenopausal women and ovariectomized
rats, there is negative bone balance, greater loss of cancellous
than the cortical regions of long bones and reductions in
bone mineral density due to declining estrogen levels (3).
Following ovariectomy, bone perforations are primarily seen
at the trabecular plates of cancellous bone (4,5), and its
strength depends on bone volume and bone structures,
which consist of connected bony plates and bone matrix (6).
After ovariectomy, the area that is initially affected is the
secondary spongiosa (central metaphyseal area) of long
bones (7). One of the agents used for osteoporosis treatment
is calcium supplementation (8). Other alternative treatments
use natural products. Polyphenols in fruits and vegetables
have demonstrated beneficial effects on bone in rats (9,10).
Natural antioxidant vitamins, such as palm tocotrienols, have
been shown to prevent bone loss in many osteoporosis-
induced ratmodels (11). Tualang honey (AgroMas, Malaysia)
is a wild, multi-floral honey produced by bees (Apis dorsata)
that form hives on the branches of giant trees named Tualang
in the Malaysian rainforest. Tualang honey has higher
phenolic content and greater radical scavenging activity
compared with other honey sources (12). Honey contains
approximately 200 substances, including a mixture of sugars
(fructose, glucose, maltose, and sucrose) and small amounts
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of other constituents, such as minerals, proteins, vitamins,
organic acids, flavonoids, phenolic acids, enzymes, and other
phytochemicals (13). A study on postmenopausal women
taking Tualang honey at 20 mg/day for four months was
found to have similar bone densitometry findings when
compared with hormone replacement therapy (14). Our
preliminary study showed the positive effects of Tualang
honey on the reproductive system and bones (15). The
present studywas conducted to further evaluate the effects of
Tualang honey on trabecular structure and to compare these
effects with those of calcium supplementation in ovariecto-
mized rats.
MATERIALS AND METHODS
The study was conducted on 40 three-month-old, virgin,
female, Sprague-Dawley rats weighing between 220 and
240 g and obtained from the Laboratory Animal Research
Unit (LARU), Health Campus, Universiti Sains Malaysia.
After acclimatization for two weeks, the rats were divided
into five groups (n = 8 per group): four controls and one test
arm. The four control arms were 1) baseline control (BC), 2)
sham-operated (SHAM group), 3) ovariectomized-control
(OVX group), and 4) ovariectomized-calcium treated (PC).
The ovariectomy and sham operation were conducted
under ketamine anesthesia. The rats were anesthetized
using 90 mg/kg ketamine (Troy Laboratories, Pty Ltd,
Australia) and 10 mg/kg xylazil (Troy Laboratories, Pty
Ltd, Australia). The BC group did not undergo ovariectomy
or a sham operation but were sacrificed at the start of the
experiment to obtain the baseline histomorphometric para-
meters. The PC group was given 1% calcium in drinking
water, which was supplied ad libitum. The calcium supple-
ment was prepared according to previous methods (16) by
adding 1 g of lactic acid hemicalcium salt (Sigma, St. Louis,
Missouri, USA) to 99 ml of deionized water to make a
concentration of 1%. Calcium supplementation was given to
the positive control group to compare the effects of honey
administration with calcium supplementation. The control
rats (SHAM and OVX) were given 0.5 ml of distilled water.
The rats in the test arm (TH group) also had bilateral
ovariectomy under ketamine anesthesia. The rats in the TH
group were given 0.2 g/kg body weight of Tualang honey.
Tualang honey was freshly prepared every morning by
dissolving the honey in deionized water. The administration
of test and control materials was started at day 14 after post-
surgery day 1 by oral gavage (9:00-10:00 am daily for six
weeks). The Tualang honey used was supplied by the Fede-
ral Agricultural Marketing Authority (FAMA), Ministry of
Agriculture and Agro-Based Industry, Malaysia. The honey
was filtered to remove solid particles, concentrated in an
oven at 40 C˚ and subjected to c irradiation at 25 kGy at
Sterilgamma (M) Sdn. Bhd. (Selangor, Malaysia). Through-
out the treatment period, a daily vaginal smear was taken,
while body weights and total food intake were recorded
weekly. The vaginal smear cytology was performed by a
licensed cytologist according to a previously described
method (17).
After six weeks, the rats were sacrificed 24 hours after the
last dose of treatment under excess ketamine anesthesia (100
mg/kg). The right femur was harvested, and the distal
section was longitudinally cut and then fixed in 10%
formalin. The bone was processed without decalcification
in methyl methacrylate (BDH, Poole, England) medium. The
bone was dehydrated with a series of ethanol solutions
(70%, 90%, and 100%) and then infiltrated in methyl
methacrylate. The bone was sectioned at 9 mm thickness
using a microtome (Leica RM2155, Nussloch, Germany).
The sections were stained with von Kossa and subjected to
histomorphometry examination using a light microscope
(Leica DMRXA2, Wetzlar, Germany) attached to an image
analyzer with VideoTest-Master software (VT, St. Peters-
burg, Russia). All histomorphometric parameter measure-
ments were performed randomly at the metaphyseal region,
which was located 3-7 mm from the lowest point of the
growth plate and 1 mm from the lateral cortex, excluding
the endocortical region (Figure 1). All measurements and
calculations were performed according to the American
Society for Bone and Mineral Research (ASBMR) nomen-
clature and guidelines (18). Structural parameters were
analyzed using an image analyzer (Leica DMRXA2,
Wetzlar, Germany) with VideoTest-Master software (VT,
St. Petersburg, Russia). First, total trabecular bone area, total
tissue area and bone perimeters (primary data) were
measured using this software. Then, these primary data
were expressed in three-dimensional form as follows: total
trabecular bone volume (bone volume, BV), total tissue
volume (tissue volume, TV) and total bone surface (bone
surface, BS). Finally, the structural parameters were calcu-
lated based on these primary data, as shown in Table 1.
The sample size was calculated using PS Power and
Sample Size Calculation version 2.1.31 and based on a
Figure 1 - Metaphyseal region of longitudinal section of distal
femur. All histomorphometric parameter measurements were
performed randomly at the metaphyseal region, which was
located 3-7 mm from the lowest point of the growth plate and 1
mm from the lateral cortex, excluding the endocortical region.
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previous study conducted by Hermizi et al. (19). The power
of the study was set at 80%, with a 95% confident interval,
while the standard deviation (s) observed was 1.4 of
trabecular thickness, and the difference in population means
(d) was set at 3.0 of the trabecular thickness. The calculated
sample size was eight per group. The data analysis was
completed using the Statistical Package for Social Sciences
(SPSS version 12.0.1) software. The Kolmogorov-Smirnov
test was used to test for normality. For the non-parametric
statistics, the Kruskal-Wallis test for multiple comparisons
was used due to the lack of a normal distribution for all
data, followed by the Mann-Whitney U test to compare
differences between the two groups. The results are
expressed as the median and interquartile range (IR: the
difference between the 75th and 25th percentile). P-values of
less than 0.05 were considered statistically significant.
The protocol used in this study was approved by the
Animal Ethics Committee, Universiti Sains Malaysia
(approval no. PPSG/07(A)/044).
RESULTS
The results show that providing Tualang honey had
positive effects on bone structures (Table 2) but not on the
body weight of ovariectomized rats (Table 3). The ovar-
iectomized rats treated with Tualang honey (TH group) had
a significant increase in bone volume per tissue volume
(BV/TV); the trabecular thickness (Tb.Th), trabecular
number (Tb.N), and inter-trabecular space (Tb.Sp) were
significantly lower in the TH group compared with the OVX
group (Table 2). In contrast, 1% calcium treatment in the PC
group did not significantly improve these parameters when
compared with the OVX group. The trabecular thickness
(Tb.Th) in the TH group was higher compared with the PC
group, and the inter-trabecular space (Tb.Sp) was narrower
compared with the PC group. The histomorphometrical
analysis of bone structures showed that the bone volume
per tissue volume (BV/TV), trabecular thickness (Tb.Th)
and trabecular number (Tb.N) were significantly decreased
in the OVX group compared with the SHAM and baseline
control (BC) groups (Table 2 and Figure 2). Only the inter-
trabecular space (Tb.Sp) was significantly increased in the
OVX group compared with the SHAM and BC groups. The
SHAM group showed significantly lower changes in body
weight compared with the OVX, TH, and PC groups
(Table 3). Rats treated with Tualang honey showed the
same body weight changes as rats in the OVX control
groups. No changes in femur weight were observed in the
TH and PC groups compared with the OVX group (Table 4).
However, there was a significant decrease in femur weight
for the OVX, TH, and PC groups compared with the SHAM
group.
DISCUSSION
Our study shows that Tualang honey improved the
trabecular structure of the femur bone in ovariectomized
rats, an animal model for the menopausal state. The effect of
Tualang honey was better than that observed in the rats that
received calcium, indicating that honey supplementation
could be used to prevent osteoporosis during menopause.
The histomorphometrical analysis of bone structures at the
secondary spongiosa in the present study showed that the
trabecular bone volume (BV/TV), trabecular thickness
(Tb.Th) and trabecular number (Tb.N) were decreased,
while the inter-trabecular space (Tb.Sp) was increased in the
OVX control group compared with the SHAM group. The
changes in trabecular bone structure parameters in the OVX
control group were due to an imbalance in the normal
remodeling process. We observed that Tualang honey
prevented this change. The improvements observed in all
structural parameters indicate that Tualang honey is
effective in the prevention of ovariectomy-induced bone
loss due to bone resorption. Tualang honey appears to be
more efficacious than calcium supplementation.
Honey is a natural beehive product well known for its high
phytochemical content (phenolic compounds or polyphenols
that contribute to positive physiological effects). Honey is
rich in antioxidants, such as flavonoids and phenolic acids
(20-23). Flavonoids constitute the most important class of
Table 1 - Formula for calculating the structural parameter values.
Parameter Symbol Unit Formula
1. Trabecular bone volume BV/TV % Bone Volume (BV)/ Tissue Volume (TV)
2. Trabecular bone thickness Tb.Th mm 2/[(Bone Surface (BS)/Bone Volume (BV)]
3. Trabecular bone number Tb.N mm-1 Trabecular bone volume (BV/TV)/Trabecular thickness (Tb.Th)
4. Trabecular bone separation Tb.S mm 1/Trabecular number (Tb.N) – Trabecular thickness (Tb.Th)
Table 2 - Effects of Tualang honey on bone histomorphometry.
Control groups Test group
BC SHAM OVX PC TH
BV/TV (%) 56.15 (2.34)**, #,ˆ ˆ ˆ 38.24 (5.62)**, ˆ ˆ 21.41 (16.72) 25.31 (14.81) ## 29.13 (9.22)*, #
Tb.Th (mm) 68.79 (7.01)***, ##,ˆ ˆ ˆ 54.75 (9.30)***,ˆ ˆ ˆ 27.29 (8.66) 30.66 (7.75)### 38.64 (7.35)**, ###,ˆ ˆ
Tb.N (mm-1) 13.01 (7.02)** 13.52 (4.11)**, ˆ 7.50 (4.31) 9.00 (6.01) # 12.51 (5.10)**
Tb.Sp (mm) 90.96 (18.77)**, #,ˆ ˆ ˆ 117.35 (4.46)*, ˆ ˆ ˆ 220.27 (63.92) 230.45 (40.75)### 157.78 (32.85)*, ###,ˆ ˆ ˆ
BC = Baseline control group; SHAM= Sham-operated control group; OVX= Ovariectomized control group; TH= Tualang honey- treated group at 0.2 g/
kg/bw; PC= Positive control group (1% calcium).
All values are expressed as the median (IR).
aKruskal–Wallis test.
*p,0.05, **p,0.01 and ***p,0.001 vs. OVX control group; #p,0.05, ##p,0.01 and ###p,0.001 vs. SHAM operated group; ˆp,0.05; ˆˆp,0.01 and
ˆˆˆp,0.001 vs. PC control group (Mann-Whitney U test).
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phenolic compounds in honey and can be categorized as
flavonols, flavavones, flavones, anthocyanidins and isofla-
vones. Flavonoids found in honey include pinocembrin,
pinobanksin, chrysin, galangin, luteolin, quercetin, and
kaempferol (24). The use of flavonoids to improve post-
menopausal osteoporosis is well documented. Quercetin and
kaempferol are a subfamily of flavonoids (flavonols) reported
to have a potential role in protection against postmenopausal
osteoporosis in ovariectomized rats (25). Honey and other
plants share similar phenolic compounds or polyphenols.
Flavonols, such as quercetin and kaempferol, have been
shown to directly induce apoptosis of mature osteoclasts,
thus inhibiting bone resorption and decreasing intracellular
reactive oxygen species (ROS) in osteoclasts by a mechanism
involving estrogen receptors (ER) (25). A study on kaemp-
ferol alone indicates that it prevents ovariectomized-induced
bone loss by promoting osteoblast function (26).
The mechanisms of action of both flavonols on bone are
still not completely understood. Flavanols may interact
directly with estrogen receptors ER-ß and ER-a (25). ER-ß is
more abundant than ER-a in trabecular bone compared with
cortical bone (27); thus, a greater proportion of flavonols
might bind to trabecular bone, resulting in a greater
preservation of trabecular bone than cortical bone. Studies
on postmenopausal animals have shown that oxidative stress
has an important impact on the differentiation and function-
ing of osteoclasts (31,32); oxidative stress also induces lipid
peroxidation and H2O2 production and a decrease in
enzymatic antioxidants, such as Superoxide Dismutase
(SOD) and Glutathione Peroxidase (GPx) (31). Phenolic
glycosides have potential antioxidant activity (32) and
immunostimulatory effects (33). The composition and inter-
action of polyphenols in honey make it a unique and
excellent source of stable, free radical scavengers among
polyphenol-containing foods (34). Another component of
honey that has been shown to increase calcium absorption is
gluconic acid. Gluconic acid is a major organic acid in honey
and one of the products of the enzymatic glucose oxidase
Table 3 - Effects of Tualang honey on body weight and food intake during six-week administration.
Control groups Test group
SHAM OVX PC TH
Body weight on D1b (g) 234 (25) 262.5 (12) 259.5 (29) 258.5 (23)
Body weight at sacrifice (g) 237.5 (30) 277.5 (24) 276.0 (27) 272.5 (19)
Changes in body weight (%) 4.9 (4.77)* 12.3 (8.19) 14.3 (7.63) 14.1 (7.87)
Total food intake (g) 702.5 (80) 797.0 (230.5) 853.0 (331.25) 811.5 (138.5)
SHAM= Sham-operated control group; OVX= Ovariectomized control group;
PC = Positive control group (1% calcium); TH= Tualang honey-treated group at 0.2 g/kg/bw.
All values are expressed as the median (IR).
aKruskal–Wallis test.
bD1: First day of treatment.
*p,0.05 vs. OVX control group (Mann-Whitney U test).
Figure 2 - Effects of Tualang honey on structure of femur bone. All pictures are stained with Von Kossa and examined under X20
magnification: BC=Baseline control group; SHAM=Sham- operated control group; OVX=Ovariectomised control group; TH=Tualang
honey treated group at 0.2 g/kg/bw; PC=Positive control group (1% calcium).
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reaction (35). It is significantly useful in the modulation of
intestinal calcium absorption calcium (36). When ingested in
food, gluconic acid is fermented by lactic acid bacteria
(Lactobacillus reuteri and L. mucosae) to produce lactate and
acetate. Acid-utilizing bacteria (Megasphaera elsdenii and
Mitsuokella multiacida) then convert these products to form
butyrate, a type of short-chain fatty acid (SCFA) that is
rapidly absorbed by the mucosa of the large intestine (37).
The greater efficacy of Tualang honey compared with
calcium supplementation is likely due to the enhancement
in intestinal calcium absorption caused by honey.
Tualang honey did not produce any adverse effects on
body weight or food intake. Although not statistically
significant, we observed that the body weight of the
ovariectomized rats treated with Tualang honey was lower
than that of the ovariectomized rats not given honey. This
observation, if translated to humans, indicates that honey
has the potential to reduce health problems related to
overweight and obesity seen in the menopausal state, such
as chronic osteoarthritis, cardiovascular diseases and some
cancers. The limitation in the interpretation of this finding is
the short study duration, which was only six weeks. It
would be interesting to observe the effect of honey over a
longer study period. Our findings were similar to the results
of several previous studies on natural products. Treatment
with kaempferol, which is highly abundant in Ginkgo biloba
extracts, did not suppress increases in body weights in
ovariectomized rats (27). Although the study period was
longer [10 weeks], the duration of the study was similar to
ours, as treatment was started at week 4 after ovariectomy.
In conclusion, Tualang honey improved the trabecular
structure of bone in ovariectomized rats. The effect of
Tualang honey in rats is better than the effects observed in
rats that received calcium. These findings suggest that
Tualang honey is better than calcium supplementation in
preventing osteoporosis in the menopausal state. Therefore,
Tualang honey could potentially be used as an alternative to
calcium supplementation in osteoporosis treatment.
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